scispace - formally typeset
Search or ask a question
Journal ArticleDOI

A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement

TL;DR: A large family with a late-onset phenotype including motor neuron disease, cognitive decline resembling frontotemporal dementia, cerebellar ataxia and myopathy is reported, showing that mitochondrial disease may be at the origin of some of these phenotypes.
Abstract: Mitochondrial DNA instability disorders are responsible for a large clinical spectrum, among which amyotrophic lateral sclerosis-like symptoms and frontotemporal dementia are extremely rare. We report a large family with a late-onset phenotype including motor neuron disease, cognitive decline resembling frontotemporal dementia, cerebellar ataxia and myopathy. In all patients, muscle biopsy showed ragged-red and cytochrome c oxidase-negative fibres with combined respiratory chain deficiency and abnormal assembly of complex V. The multiple mitochondrial DNA deletions found in skeletal muscle revealed a mitochondrial DNA instability disorder. Patient fibroblasts present with respiratory chain deficiency, mitochondrial ultrastructural alterations and fragmentation of the mitochondrial network. Interestingly, expression of matrix-targeted photoactivatable GFP showed that mitochondrial fusion was not inhibited in patient fibroblasts. Using whole-exome sequencing we identified a missense mutation (c.176C>T; p.Ser59Leu) in the CHCHD10 gene that encodes a coiled-coil helix coiled-coil helix protein, whose function is unknown. We show that CHCHD10 is a mitochondrial protein located in the intermembrane space and enriched at cristae junctions. Overexpression of a CHCHD10 mutant allele in HeLa cells led to fragmentation of the mitochondrial network and ultrastructural major abnormalities including loss, disorganization and dilatation of cristae. The observation of a frontotemporal dementia-amyotrophic lateral sclerosis phenotype in a mitochondrial disease led us to analyse CHCHD10 in a cohort of 21 families with pathologically proven frontotemporal dementia-amyotrophic lateral sclerosis. We identified the same missense p.Ser59Leu mutation in one of these families. This work opens a novel field to explore the pathogenesis of the frontotemporal dementia-amyotrophic lateral sclerosis clinical spectrum by showing that mitochondrial disease may be at the origin of some of these phenotypes.

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI
10 Nov 2016-Nature
TL;DR: Extraordinary progress in understanding the biology of ALS provides new reasons for optimism that meaningful therapies will be identified, and emerging themes include dysfunction in RNA metabolism and protein homeostasis, with specific defects in nucleocytoplasmic trafficking.
Abstract: Amyotrophic lateral sclerosis (ALS) is a progressive and uniformly fatal neurodegenerative disease. A plethora of genetic factors have been identified that drive the degeneration of motor neurons in ALS, increase susceptibility to the disease or influence the rate of its progression. Emerging themes include dysfunction in RNA metabolism and protein homeostasis, with specific defects in nucleocytoplasmic trafficking, the induction of stress at the endoplasmic reticulum and impaired dynamics of ribonucleoprotein bodies such as RNA granules that assemble through liquid-liquid phase separation. Extraordinary progress in understanding the biology of ALS provides new reasons for optimism that meaningful therapies will be identified.

1,382 citations

Journal ArticleDOI
27 Mar 2015-Science
TL;DR: A moderate-scale sequencing study aimed at increasing the number of genes known to contribute to predisposition for ALS found several known ALS genes were found to be associated, and TBK1 (the gene encoding TANK-binding kinase 1) was identified as an ALS gene.
Abstract: Amyotrophic lateral sclerosis (ALS) is a devastating neurological disease with no effective treatment. We report the results of a moderate-scale sequencing study aimed at increasing the number of genes known to contribute to predisposition for ALS. We performed whole-exome sequencing of 2869 ALS patients and 6405 controls. Several known ALS genes were found to be associated, and TBK1 (the gene encoding TANK-binding kinase 1) was identified as an ALS gene. TBK1 is known to bind to and phosphorylate a number of proteins involved in innate immunity and autophagy, including optineurin (OPTN) and p62 (SQSTM1/sequestosome), both of which have also been implicated in ALS. These observations reveal a key role of the autophagic pathway in ALS and suggest specific targets for therapeutic intervention.

813 citations

Journal ArticleDOI
TL;DR: Two possible disease-modifying therapies that can slow disease progression are available for ALS, but patient management is largely mediated by symptomatic therapies, such as the use of muscle relaxants for spasticity and speech therapy for dysarthria.

540 citations

Journal ArticleDOI
TL;DR: Interestingly, these cellular processes are also implicated in more-common complex neurodegenerative disorders, such as Alzheimer disease and Parkinson disease, indicating a common pathological thread and a close relationship with mitochondrial structure, function and localization.
Abstract: Mitochondria form a highly interconnected tubular network throughout the cell via a dynamic process, with mitochondrial segments fusing and breaking apart continuously. Strong evidence has emerged to implicate disturbed mitochondrial fusion and fission as central pathological components underpinning a number of childhood and adult-onset neurodegenerative disorders. Several proteins that regulate the morphology of the mitochondrial network have been identified, the most widely studied of which are optic atrophy 1 and mitofusin 2. Pathogenic mutations that disrupt these two pro-fusion proteins cause autosomal dominant optic atrophy and axonal Charcot-Marie-Tooth disease type 2A, respectively. These disorders predominantly affect specialized neurons that require precise shuttling of mitochondria over long axonal distances. Considerable insight has also been gained by carefully dissecting the deleterious consequences of imbalances in mitochondrial fusion and fission on respiratory chain function, mitochondrial quality control (mitophagy), and programmed cell death. Interestingly, these cellular processes are also implicated in more-common complex neurodegenerative disorders, such as Alzheimer disease and Parkinson disease, indicating a common pathological thread and a close relationship with mitochondrial structure, function and localization. Understanding how these fundamental processes become disrupted will prove crucial to the development of therapies for the growing number of neurodegenerative disorders linked to disturbed mitochondrial dynamics.

539 citations

Journal Article
TL;DR: In this paper, mutations in the OPA1 gene can also be responsible for a syndromic form of DOA associated with sensorineural deafness, ataxia, axonal sensory-motor polyneuropathy, chronic progressive external ophthalmoplegia and mitochondrial myopathy.
Abstract: Mutations in OPA1, a dynamin-related GTPase involved in mitochondrial fusion, cristae organization and control of apoptosis, have been linked to non-syndromic optic neuropathy transmitted as an autosomal-dominant trait (DOA). We here report on eight patients from six independent families showing that mutations in the OPA1 gene can also be responsible for a syndromic form of DOA associated with sensorineural deafness, ataxia, axonal sensory-motor polyneuropathy, chronic progressive external ophthalmoplegia and mitochondrial myopathy with cytochrome c oxidase negative and Ragged Red Fibres. Most remarkably, we demonstrate that these patients all harboured multiple deletions of mitochondrial DNA (mtDNA) in their skeletal muscle, thus revealing an unrecognized role of the OPA1 protein in mtDNA stability. The five OPA1 mutations associated with these DOA 'plus' phenotypes were all mis-sense point mutations affecting highly conserved amino acid positions and the nuclear genes previously known to induce mtDNA multiple deletions such as POLG1, PEO1 (Twinkle) and SLC25A4 (ANT1) were ruled out. Our results show that certain OPA1 mutations exert a dominant negative effect responsible for multi-systemic disease, closely related to classical mitochondrial cytopathies, by a mechanism involving mtDNA instability.

394 citations

References
More filters
Journal ArticleDOI
TL;DR: This assay is very reproducible and rapid with the dye binding process virtually complete in approximately 2 min with good color stability for 1 hr with little or no interference from cations such as sodium or potassium nor from carbohydrates such as sucrose.

225,085 citations


"A mitochondrial origin for frontote..." refers methods in this paper

  • ...Proteins were measured according to Bradford microassay (Bradford, 1976)....

    [...]

  • ...Proteins were measured according to Bradford microassay (Bradford, 1976). mtDNA molecular analysis Total DNA was extracted using standard phenol chloroform procedure....

    [...]

Journal ArticleDOI
TL;DR: This protocol provides a guide to interpreting the output of structure prediction servers in general and one such tool in particular, the protein homology/analogy recognition engine (Phyre), which can reliably detect up to twice as many remote homologies as standard sequence-profile searching.
Abstract: Determining the structure and function of a novel protein is a cornerstone of many aspects of modern biology. Over the past decades, a number of computational tools for structure prediction have been developed. It is critical that the biological community is aware of such tools and is able to interpret their results in an informed way. This protocol provides a guide to interpreting the output of structure prediction servers in general and one such tool in particular, the protein homology/analogy recognition engine (Phyre). New profile–profile matching algorithms have improved structure prediction considerably in recent years. Although the performance of Phyre is typical of many structure prediction systems using such algorithms, all these systems can reliably detect up to twice as many remote homologies as standard sequence-profile searching. Phyre is widely used by the biological community, with >150 submissions per day, and provides a simple interface to results. Phyre takes 30 min to predict the structure of a 250-residue protein.

4,403 citations


"A mitochondrial origin for frontote..." refers methods in this paper

  • ...15 Homology modelling of human CHCHD10 16 Using the threading program PHYRE2 (Kelley et al., 2009), 142 residues of CHCHD10 17 (Met1 to Pro142) were modeled using CHCHD5 as template (PDB ID: 2LQL)....

    [...]

  • ...Homology modelling of human CHCHD10 Using the threading program PHYRE2 (Kelley et al., 2009), 142 residues of CHCHD10 (Met1 to Pro142) were modeled using CHCHD5 as template (PDB ID: 2LQL)....

    [...]

  • ...Using the threading program PHYRE2 (Kelley and Sternberg, 2009), 142 residues of CHCHD10 (Met1 to Pro142) were modelled using CHCHD5 as template (PDB ID: 2LQL)....

    [...]

Journal ArticleDOI
20 Oct 2011-Neuron
TL;DR: It is found that repeat expansion in C9ORF72 is a major cause of both FTD and ALS, suggesting multiple disease mechanisms.

4,153 citations


"A mitochondrial origin for frontote..." refers background in this paper

  • ...We identified the same missense p.Ser59Leu mutation in one of these FTD-ALS families....

    [...]

  • ...FTD-ALS is a genetically 12 heterogeneous disorder and a hexanucleotide repeat expansion in a noncoding region of the 13 chromosome 9 open reading frame 72 (C9ORF72) gene, the function of which is unknown, 14 has been recently identified as a common cause of FTD-ALS (DeJesus-Hernandez et al., 15 2001; Renton et al., 2011)....

    [...]

  • ...20 The observation of a frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) 21 phenotype in a mitochondrial disease led us to analyse CHCHD10 in a cohort of 21 families 22 with pathologically proven FTD-ALS....

    [...]

  • ...This observation led us to analyse 10 CHCHD10 in FTD-ALS families with a dominant mode of transmission and to identify the 11 same missense p.Ser59Leu mutation in one of these families....

    [...]

  • ...This observation led us to analyse CHCHD10 in FTD-ALS families with a dominant mode of transmission and to identify the same missense p.Ser59Leu mutation in one of these families....

    [...]

Journal ArticleDOI
Alan E. Renton1, Elisa Majounie1, Adrian James Waite2, Javier Simón-Sánchez3, Javier Simón-Sánchez4, Sara Rollinson5, J. Raphael Gibbs1, J. Raphael Gibbs6, Jennifer C. Schymick1, Hannu Laaksovirta7, John C. van Swieten3, John C. van Swieten4, Liisa Myllykangas7, Hannu Kalimo7, Anders Paetau7, Yevgeniya Abramzon1, Anne M. Remes8, Alice Kaganovich1, Sonja W. Scholz1, Sonja W. Scholz9, Sonja W. Scholz10, Jamie Duckworth1, Jinhui Ding1, Daniel W. Harmer11, Dena G. Hernandez6, Dena G. Hernandez1, Janel O. Johnson6, Janel O. Johnson1, Kin Y. Mok6, Mina Ryten6, Danyah Trabzuni6, Rita Guerreiro6, Richard W. Orrell6, James Neal2, Alexandra Murray12, J. P. Pearson2, Iris E. Jansen3, David Sondervan3, Harro Seelaar4, Derek J. Blake2, Kate Young5, Nicola Halliwell5, Janis Bennion Callister5, Greg Toulson5, Anna Richardson5, Alexander Gerhard5, Julie S. Snowden5, David M. A. Mann5, David Neary5, Mike A. Nalls1, Terhi Peuralinna7, Lilja Jansson7, Veli-Matti Isoviita7, Anna-Lotta Kaivorinne8, Maarit Hölttä-Vuori7, Elina Ikonen7, Raimo Sulkava13, Michael Benatar14, Joanne Wuu14, Adriano Chiò15, Gabriella Restagno, Giuseppe Borghero16, Mario Sabatelli17, David Heckerman18, Ekaterina Rogaeva19, Lorne Zinman19, Jeffrey D. Rothstein9, Michael Sendtner20, Carsten Drepper20, Evan E. Eichler21, Can Alkan21, Ziedulla Abdullaev1, Svetlana Pack1, Amalia Dutra1, Evgenia Pak1, John Hardy6, Andrew B. Singleton1, Nigel Williams2, Peter Heutink3, Stuart Pickering-Brown5, Huw R. Morris2, Huw R. Morris12, Huw R. Morris22, Pentti J. Tienari7, Bryan J. Traynor1, Bryan J. Traynor9 
20 Oct 2011-Neuron
TL;DR: The chromosome 9p21 amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) locus contains one of the last major unidentified autosomal-dominant genes underlying these common neurodegenerative diseases, and a large hexanucleotide repeat expansion in the first intron of C9ORF72 is shown.

3,784 citations


"A mitochondrial origin for frontote..." refers background in this paper

  • ...…12 heterogeneous disorder and a hexanucleotide repeat expansion in a noncoding region of the 13 chromosome 9 open reading frame 72 (C9ORF72) gene, the function of which is unknown, 14 has been recently identified as a common cause of FTD-ALS (DeJesus-Hernandez et al., 15 2001; Renton et al., 2011)....

    [...]

  • ...We identified the same missense p.Ser59Leu mutation in one of these FTD-ALS families....

    [...]

  • ...FTD-ALS is a genetically 12 heterogeneous disorder and a hexanucleotide repeat expansion in a noncoding region of the 13 chromosome 9 open reading frame 72 (C9ORF72) gene, the function of which is unknown, 14 has been recently identified as a common cause of FTD-ALS (DeJesus-Hernandez et al., 15 2001; Renton et al., 2011)....

    [...]

  • ...20 The observation of a frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) 21 phenotype in a mitochondrial disease led us to analyse CHCHD10 in a cohort of 21 families 22 with pathologically proven FTD-ALS....

    [...]

  • ...This observation led us to analyse 10 CHCHD10 in FTD-ALS families with a dominant mode of transmission and to identify the 11 same missense p.Ser59Leu mutation in one of these families....

    [...]

Journal ArticleDOI
TL;DR: It is concluded that the primary gene mutated in CMT2A is MFN2, and seven large pedigrees affected with Charcot-Marie-Tooth neuropathy type 2A are concluded.
Abstract: We report missense mutations in the mitochondrial fusion protein mitofusin 2 (MFN2) in seven large pedigrees affected with Charcot-Marie-Tooth neuropathy type 2A (CMT2A). Although a mutation in kinesin family member 1B-β (KIF1B) was associated with CMT2A in a single Japanese family, we found no mutations in KIF1B in these seven families. Because these families include all published pedigrees with CMT2A and are ethnically diverse, we conclude that the primary gene mutated in CMT2A is MFN2.

1,479 citations


"A mitochondrial origin for frontote..." refers background in this paper

  • ...MFN2 mutations are a major cause of primary axonal Charcot-Marie-Tooth Page 4 of 81 ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901 Support (434) 964 4100 Brain For Peer Review 4 disease type 2A (CMT2A) (Zuchner et al., 2004), an autosomal dominant neuropathy that impairs motor and sensory neurons with the longest axons resulting in earliest symptoms in distal extremities....

    [...]

  • ...…54 of 81 ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901 Support (434) 964 4100 Brain For Peer Review 4 disease type 2A (CMT2A) (Zuchner et al., 2004), an autosomal dominant neuropathy that 1 impairs motor and sensory neurons with the longest axons resulting in earliest…...

    [...]

  • ...…4 of 81 ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901 Support (434) 964 4100 Brain For Peer Review 4 disease type 2A (CMT2A) (Zuchner et al., 2004), an autosomal dominant neuropathy that impairs motor and sensory neurons with the longest axons resulting in earliest symptoms…...

    [...]

  • ...MFN2 mutations are a major cause of primary axonal Charcot-Marie-Tooth 26 Page 54 of 81 ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901 Support (434) 964 4100 Brain For Peer Review 4 disease type 2A (CMT2A) (Zuchner et al., 2004), an autosomal dominant neuropathy that 1 impairs motor and sensory neurons with the longest axons resulting in earliest symptoms in 2 distal extremities....

    [...]

  • ...MFN2 mutations are a major cause of primary axonal Charcot–Marie–Tooth disease type 2A (CMT2A) (Zuchner et al., 2004), an autosomal dominant neuropathy that impairs motor and sensory neurons with the longest axons resulting in earliest symptoms in distal extremities....

    [...]

Related Papers (5)
20 Oct 2011-Neuron